Almac relaunches IVR/IWR platform targeting small and mid-sized firms
The IVR/IWR system – formerly known as WebEZ but now relaunched as aXcess – is a web-based platform used to randomise patients to particular treatment or control groups during clinical trials.
Northern Ireland, UK-based Almac claims aXcess is “a unique alternative to using paper based or manual systems to automate patient randomization and supply chain management for small to mid-sized studies.”
Donna Christopher, VP of Operations said: "The new IVR/IWR system, aXcess, coupled with our clinical packaging and distribution bundle gives companies who would typically utilize a paper based approach to randomization and supply chain management an alternative option. This option more effectively manages the trials our clients are conducting at a cost that works within their budgetary restrictions."
The system is part of Almac’s wider automated clinical packaging and distribution offering, the North American arm of which was recently bolstered by an expanded US facility.
